CAPITOL COUNSEL LLC for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
340B issues and patient access to pharmaceuticals.
Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CAITLIN CANTER | — |
| AARON COHEN | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| DENISE HENRY MORRISEY | — |
| ANN JABLON | — |
Medicare/Medicaid MMM
Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, and related provisions in S. 2543, the Prescription Drug Pricing Reduction Act, and H.R. 3, the Lower Drug Costs Now Act, including provisions regarding Medicare Parts B and D; and use of step therapy in Medicare and health insurance coverage.
Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CAITLIN CANTER | — |
| AARON COHEN | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| DENISE HENRY MORRISEY | — |
| ANN JABLON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.